Clinical Effectiveness and Cost‐Effectiveness of Misoprostol in Comparison to Dilatation and Curettage for Treatment of First‐Trimester Missed Abortion (Gestational Age ≤ 14 Weeks) in Iran
This study indicates that using misoprostol administered in hospitals for first-trimester induced abortions in Iran not only reduces societal costs but also improves quality of life compared to both D&C procedures and clinic-based misoprostol administration.
Authors
- Saeed Husseini Barghazan (ORCID: https://orcid.org/0000-0002-5322-2438)
- Zahra Meshkani (ORCID: https://orcid.org/0000-0001-7994-2567)
- Aziz Rezapour (ORCID: https://orcid.org/0000-0002-5583-5561)
- Setare Nassiri (ORCID: https://orcid.org/0000-0002-6900-7345)
- Soheila Norouzi (ORCID: https://orcid.org/0000-0002-3028-7861)
- Mohamad Hadian (ORCID: https://orcid.org/0000-0001-5897-659X)
Institutions
- Iran University of Medical Sciences (IR)
- Iran National Science Foundation (IR)
- Urmia University (IR)
- National Health Insurance Fund (RS)
Publication Details
- Journal
- Health Science Reports
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/hsr2.71662
- Primary Topic
- Reproductive Health and Contraception
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Iran University of Medical Sciences